XML 38 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Share-based Arrangements
6 Months Ended
Jul. 01, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Share-based Payment Arrangement
17. SHARE-BASED ARRANGEMENTS

The Company accounts for stock options, restricted stock awards ("RSAs"), restricted stock units and performance stock units ("PSUs") as equity awards and measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the statement of operations. The Company also has an employee stock purchase plan, which is accounted for as a liability award. Compensation expense for stock options, RSAs, restricted stock units and PSUs is recognized on a straight-line basis over the vesting period of the awards. Throughout the course of the vesting period, the Company monitors the achievement level for the ROIC metric of the PSUs compared to the ROIC target and adjusts the number of shares expected to be earned, and the related compensation expense recorded thereafter, to reflect the most probable outcome. Share-based compensation expense recorded for the three-month and six-month fiscal periods ended July 1, 2022 was $2.7 million and $4.8 million, respectively. Of these amounts, $0.1 million was recorded to restructuring and severance costs in both periods, and the remaining amounts were recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations. Share-based compensation expense recorded for the three-month and six-month fiscal periods ended July 2, 2021 was $2.5 million and $4.2 million, respectively. Of these amounts, $0.2 million was recorded to restructuring and severance costs in both periods, and the remaining amounts were recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations.

Stock option activity was as follows:
For the Three Months EndedFor the Six Months Ended
July 1, 2022July 1, 2022
OptionsWeighted - average
exercise price
OptionsWeighted - average
exercise price
Options outstanding at beginning of period733,493 $55.29 746,240 $55.14 
Granted— $— — $— 
Exercised— $42.86 (9,676)$41.90 
Forfeited or expired(6,802)$53.53 (9,873)$40.41 
Options outstanding at July 1, 2022
726,691 $55.32 726,691 $55.32 

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. No options were granted in the six-month fiscal period ended July 1, 2022. The following table indicates the weighted-average assumptions used in estimating fair value for the six-month fiscal period ended July 2, 2021:
For the Six Months Ended
 July 2, 2021
Expected option term (years)4.9
Expected volatility35.7 %
Risk-free interest rate0.5 %
Expected dividend yield1.6 %
Per share fair value of options granted$14.89 
17. SHARE-BASED ARRANGEMENTS (CONTINUED)

Restricted stock award and restricted stock unit activity were as follows:
For the Three Months EndedFor the Six Months Ended
July 1, 2022July 1, 2022
 Restricted  StockWeighted-
average grant
date fair value
Restricted  StockWeighted-
average grant
date fair value
Restricted Stock outstanding at beginning of period164,791 $47.96 135,351 $53.53 
Granted19,900 $43.15 100,015 $41.94 
Vested(28,731)$44.84 (75,329)$49.80 
Forfeited or expired(3,760)$50.00 (7,837)$51.51 
Restricted Stock outstanding at July 1, 2022
152,200 $47.87 152,200 $47.87 

Performance stock unit activity was as follows:
For the Three Months EndedFor the Six Months Ended
July 1, 2022July 1, 2022
 Performance StockWeighted-
average grant
date fair value
Performance StockWeighted-
average grant
date fair value
Performance Stock outstanding at beginning of period184,405 $60.98 70,163 $70.17 
Granted(1)
— $— 117,885 $54.87 
Vested— $— — $— 
Forfeited or expired(4,285)$61.38 (7,928)$61.32 
Performance Stock outstanding at July 1, 2022
180,120 $60.55 180,120 $60.55 
(1) The PSUs granted in 2022 and 2021 assumed a 100% achievement level.

The fair value of the PSUs based on TSR was estimated on the date of grant using a Monte-Carlo simulation model. The following table indicates the weighted-average assumptions used in estimating fair value:
For the Six Months Ended
 July 1, 2022July 2, 2021
Expected term (years)2.92.9
Expected volatility39.4 %41.3 %
Risk-free interest rate1.7 %0.2 %
Expected dividend yield1.9 %1.4 %
Per share fair value of performance stock granted$68.10$84.49